Trial Profile
Budesonide for Mycophenolic Acid (MPA)-Induced Diarrhea in Renal Transplant Recipients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 May 2019
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- 16 May 2019 Status changed from recruiting to discontinued.
- 03 Apr 2018 Planned End Date changed from 1 Apr 2018 to 1 Apr 2019.
- 03 Apr 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Apr 2019.